ChemAbout

ChemAbout is a B2B platform where chemical buyers and suppliers discover each other.

Post a purchase requestList your products (for suppliers)
© 2026 ChemAbout
Compound Index|Demand Board|Insights|Exhibitions|Compliance|Help Center|Privacy Policy|Terms of Service|[email protected]
Home/Compounds/API/Lecirelin
C59H84N16O12
1209.4 g/mol
APIDanger

Dalmarelin

CAS61012-19-9
Category
API
Compound Class
Peptide
Primary Use
Pharmaceutical Raw Material

Dalmarelin is a synthetic peptide compound used as an active pharmaceutical ingredient. It is a complex molecule with multiple amide bonds and ring structures, typical of peptide-based pharmaceuticals.

Content scope: Information here supports chemical identification and industrial supply, research, and manufacturing contexts. It is not a therapeutic claim, medical advice, or drug-use instructions.

Sourcing Dalmarelin?

Post a free purchase request — no account needed. It reaches suppliers of this product, and replies go straight to your inbox.

Post a Purchase Request→Supplier? List your product for this CAS→

Related Compounds

SimilarStructure SimilarSimilarity 0.83

Leuprolide EP impurity D

CAS1926163-25-8

pharmaceutical raw material

SimilarStructure SimilarSimilarity 0.83

Histrelin

CAS76712-82-8

pharmaceutical raw material

SimilarStructure SimilarSimilarity 0.83

(Des-Gly10,D-His2,D-His(Bzl)6,Pro-NHEt9)-LHRH

CAS134009-10-2

pharmaceutical raw material

SimilarStructure SimilarSimilarity 0.83

Histrelin acetate

CAS220810-26-4

pharmaceutical raw material

ReferenceSame Category

Acarbose EP Impurity C

CAS610271-07-3

pharmaceutical raw material

ReferenceSame Category

Teicoplanin

CAS61036-62-2

pharmaceutical raw material

ReferenceSame Category

Levothyroxine sodium pentahydrate

CAS6106-07-6

pharmaceutical raw material

ReferenceSame Category

Scopolamine aminoxide hydrobromide

CAS6106-81-6

pharmaceutical raw material

Related Reading

Therapeutic Peptides in 2026: This Year's Breakthroughs

2026 has been a concentrated year for peptide therapeutics. Efficacy reached a new high in late-stage trials, the obesity field moved beyond the incretins to amylin, the oral route reached weight management, and peptide-guided radioligand therapy kept advancing — each point tied to a specific 2025–2026 result.

Read more

Safety Reference

Health Hazard
Health Hazard
Danger
H360May damage fertility or the unborn child
Identifiers
IUPAC Name

(2S)-N-[(2S)-1-[[(2S)-1-[[(2S)-1-[[(2S)-1-[[(2R)-1-[[(2S)-1-[[(2S)-5-(diaminomethylideneamino)-1-[(2S)-2-(ethylcarbamoyl)pyrrolidin-1-yl]-1-oxopentan-2-yl]amino]-4-methyl-1-oxopentan-2-yl]amino]-3,3-dimethyl-1-oxobutan-2-yl]amino]-3-(4-hydroxyphenyl)-1-oxopropan-2-yl]amino]-3-hydroxy-1-oxopropan-2-yl]amino]-3-(1H-indol-3-yl)-1-oxopropan-2-yl]amino]-3-(1H-imidazol-5-yl)-1-oxopropan-2-yl]-5-oxopyrrolidine-2-carboxamide

InChIKey

XJWIEWPGHRSZJM-MGZASHDBSA-N

SMILES

CCNC(=O)[C@@H]1CCCN1C(=O)[C@H](CCCN=C(N)N)NC(=O)[C@H](CC(C)C)NC(=O)[C@@H](C(C)(C)C)NC(=O)[C@H](CC2=CC=C(C=C2)O)NC(=O)[C@H](CO)NC(=O)[C@H](CC3=CNC4=CC=CC=C43)NC(=O)[C@H](CC5=CN=CN5)NC(=O)[C@@H]6CCC(=O)N6

Synonyms (6)
  • Dalmarelin
  • Gestran
  • Lecrelin

Sourcing Dalmarelin?

Post a free purchase request — no account needed. It reaches suppliers of this product, and replies go straight to your inbox.

Post a Purchase Request→Supplier? List your product for this CAS→